Clinical Trials Directory

Trials / Unknown

UnknownNCT05589779

Relationship Between Cardiovascular Disease in Asthma and Eosinophil Subtypes and Biomarkers of Bronchial Remodeling.

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

To know the clinical and inflammatory characteristics of patients with asthma and associated cardiovascular disease.

Detailed description

Recent studies have shown that asthma could be a risk factor for cardiovascular disease, especially in the female and late-onset subgroups. The two entities share several risk factors, such as chronic inflammation and bronchial remodeling. Eosinophilia, characteristic of asthma, has also been described as a predictor of cardiovascular mortality. The aim of this study is to determine the clinical and inflammatory characteristics of patients with asthma and associated cardiovascular disease, as well as their relationship with eosinophil subtypes, biomarkers of chronic inflammation and bronchial remodeling.

Conditions

Interventions

TypeNameDescription
OTHERAsthma and cardiovascular diseaseTo know the clinical and inflammatory characteristics of patients with asthma and associated cardiovascular disease, as well as their relationship with eosinophil subtypes, biomarkers of chronic inflammation and bronchial remodeling.

Timeline

Start date
2023-04-01
Primary completion
2024-05-01
Completion
2024-08-01
First posted
2022-10-21
Last updated
2022-10-21

Source: ClinicalTrials.gov record NCT05589779. Inclusion in this directory is not an endorsement.